$11.8 Million is the total value of Atlas Venture Associates IX, LLC's 6 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 66.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SKLZ | SKILLZ INC | $5,842,009 | -44.0% | 1,145,492 | 0.0% | 49.69% | -12.9% | |
| CHRS | New | COHERUS BIOSCIENCES INC | $2,125,846 | – | 568,408 | +100.0% | 18.08% | – |
| SPRO | SPERO THERAPEUTICS INC | $1,637,497 | -16.6% | 1,353,303 | 0.0% | 13.93% | +29.7% | |
| SNAP | SNAP INCcl a | $1,337,926 | -24.7% | 150,160 | 0.0% | 11.38% | +17.0% | |
| New | SYNLOGIC INC | $496,802 | – | 176,798 | +100.0% | 4.23% | – | |
| NTLA | INTELLIA THERAPEUTICS INC | $316,200 | -22.5% | 10,000 | 0.0% | 2.69% | +20.6% | |
| SYBX | Exit | SYNLOGIC INC | $0 | – | -2,651,963 | -100.0% | -6.24% | – |
| SURF | Exit | SURFACE ONCOLOGY INC | $0 | – | -2,945,453 | -100.0% | -14.02% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| INTELLIA THERAPEUTICS INC | 28 | Q3 2023 | 100.0% |
| SNAP INC | 26 | Q3 2023 | 11.4% |
| SPERO THERAPEUTICS INC | 24 | Q3 2023 | 24.0% |
| SYNLOGIC INC | 24 | Q2 2023 | 35.6% |
| SURFACE ONCOLOGY INC | 21 | Q2 2023 | 33.3% |
| SKILLZ INC | 12 | Q3 2023 | 87.5% |
| UNUM THERAPEUTICS INC | 11 | Q3 2020 | 28.2% |
| COGENT BIOSCIENCES INC | 7 | Q2 2022 | 9.6% |
| CARBON BLACK INC | 6 | Q3 2019 | 7.8% |
| COHERUS BIOSCIENCES INC | 1 | Q3 2023 | 18.1% |
View Atlas Venture Associates IX, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-08 |
| 13F-HR | 2023-05-08 |
| 13F-HR | 2023-01-31 |
| 13F-HR | 2022-11-10 |
| 13F-HR | 2022-08-11 |
| 13F-HR | 2022-05-12 |
| 13F-HR | 2022-01-27 |
| 13F-HR | 2021-11-04 |
| 13F-HR | 2021-08-11 |
View Atlas Venture Associates IX, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.